We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$1.09B
Cap. Flow
% of AUM
-2.71%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.13% |
| 2 | Technology | 18.75% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.88% |
| 5 | Communication Services | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDLA
226
DELISTED
Medallia, Inc.
MDLA
| $41.2M | 0.1% |
1,633,820
+452,488
| +38% | +$10.8M |
|
227
Teradyne
TER
$50B
| $41.2M | 0.1% |
487,872
+17,288
| +4% | +$1.16M |
|
228
MetLife
MET
$62.4B
| $41.2M | 0.1% |
1,127,192
-24,062
| -2% | -$838K |
|
229
Ollie's Bargain Outlet
OLLI
$4.31B
| $41M | 0.1% |
420,180
+99,781
| +31% | +$7.67M |
|
230
Radware
RDWR
$983M
| $41M | 0.1% |
1,737,100
| – | – |
|
231
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $40.8M | 0.1% |
500,000
+267,600
| +115% | +$21.6M |
|
232
PPG Industries
PPG
$24.9B
| $40.7M | 0.1% |
383,482
+296,976
| +343% | +$28.6M |
|
233
Reinsurance Group of America
RGA
$15.5B
| $40.6M | 0.1% |
517,463
-39,542
| -7% | -$3.65M |
|
234
Simpson Manufacturing
SSD
$7.79B
| $40.6M | 0.1% |
480,856
-27,075
| -5% | -$2M |
|
235
Clean Harbors
CLH
$17.2B
| $40.6M | 0.1% |
676,228
-103,558
| -13% | -$5.77M |
|
236
Ryman Hospitality Properties
RHP
$8.56B
| $40.5M | 0.1% |
1,169,382
-43,427
| -4% | -$1.44M |
|
237
Okta
OKTA
$23.8B
| $40.2M | 0.1% |
200,586
+174,460
| +668% | +$29.6M |
|
238
Brown & Brown
BRO
$25.1B
| $40.1M | 0.1% |
983,690
-249,215
| -20% | -$9.61M |
|
239
Capital One
COF
$128B
| $40.1M | 0.1% |
640,103
+76,982
| +14% | +$4.79M |
|
240
Walmart Inc
WMT
$909B
| $39.9M | 0.1% |
999,894
-799,614
| -44% | -$32.9M |
|
241
Weibo
WB
$1.97B
| $39.9M | 0.1% |
1,186,481
-256,502
| -18% | -$8.8M |
|
|
CALA
242
DELISTED
Calithera Biosciences, Inc
CALA
| $39.3M | 0.1% |
371,918
+25,188
| +7% | +$2.99M |
|
|
MRUS
243
DELISTED
Merus
MRUS
| $39.2M | 0.1% |
2,439,196
+627,196
| +35% | +$9.07M |
|
|
HES
244
DELISTED
Hess
HES
| $39.2M | 0.1% |
757,376
-332,565
| -31% | -$15.2M |
|
|
KRTX
245
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $39.2M | 0.1% |
351,946
+55,535
| +19% | +$4.83M |
|
|
TPTX
246
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $39.2M | 0.1% |
607,082
+182,972
| +43% | +$10.6M |
|
247
Artisan Partners
APAM
$2.86B
| $39.1M | 0.1% |
1,201,831
+153,740
| +15% | +$4.26M |
|
248
AstraZeneca
AZN
$269B
| $38.8M | 0.1% |
367,127
+5,094
| +1% | +$526K |
|
249
Ecolab
ECL
$79.8B
| $38.8M | 0.1% |
194,796
-7,561
| -4% | -$1.46M |
|
250
HEICO Corp
HEI
$49.6B
| $38.7M | 0.1% |
388,744
-257,279
| -40% | -$23.8M |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.